AriAdPharmaceuticals.org
Visit Website |
|
edit Title
Signaling Pathways to Better Health - ARIAD
edit Description
Excerpted from the website description:
- ARIAD is developing breakthrough medicines that regulate cell-signaling pathways implicated in cancer. Our pipeline includes a series of small molecule product candidates that provide targeted and highly potent anti-cancer activity to treat solid tumors and hematologic cancers, as well as the spread of tumors to distant sites. Our lead candidate — deforolimus, a novel mTOR inhibitor—has been given fast track designation by the FDA for the treatment of soft-tissue and bone sarcomas.
edit Languages
English


